SAR Ship Target Sequential 3-D Reconstruction Technology via Time-Variant Mapping Based on Implicit Neural Representation
IEEE Transactions on Aerospace and Electronic Systems · 2026 · 62 · 19677-19697
DOI: 10.1109/taes.2026.3740649 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Aerospace and Electronic Systems, 2026. Verfasst von Jiawei Huo und 6 weiteren Autor:innen. Gefördert von: National Natural Science Foundation of China, 2025 Postdoctoral Innovation Talent Support Program, Open Fund of the State Key Laboratory of Microwave Imaging, Aerospace Information Research Institute, Chinese Academy of Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- 2025 Postdoctoral Innovation Talent Support Program
- Open Fund of the State Key Laboratory of Microwave Imaging, Aerospace Information Research Institute, Chinese Academy of Sciences
- Youth Science Fund Category B of the Natural Science Foundation of Sichuan Province
Zitieren
APA
Huo, J., Li, Z., Yang, Q., Hai, Y., Ao, W., Wu, J., & Yang, J. (2026). SAR Ship Target Sequential 3-D Reconstruction Technology via Time-Variant Mapping Based on Implicit Neural Representation. IEEE Transactions on Aerospace and Electronic Systems, 62, 19677-19697. https://doi.org/10.1109/taes.2026.3740649
Vancouver
Huo J, Li Z, Yang Q, Hai Y, Ao W, Wu J, et al. SAR Ship Target Sequential 3-D Reconstruction Technology via Time-Variant Mapping Based on Implicit Neural Representation. IEEE Transactions on Aerospace and Electronic Systems. 2026;62:19677-19697. doi:10.1109/taes.2026.3740649
BibTeX
@article{Huo2026,
author = {Huo, Jiawei and Li, Zhongyu and Yang, Qing and Hai, Yu and Ao, Weihong and Wu, Junjie and Yang, Jianyu},
title = {SAR Ship Target Sequential 3-D Reconstruction Technology via Time-Variant Mapping Based on Implicit Neural Representation},
journal = {IEEE Transactions on Aerospace and Electronic Systems},
year = {2026},
volume = {62},
pages = {19677--19697},
doi = {10.1109/taes.2026.3740649}
}
EUVIMED